La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Poly Medicure Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Poly Medicure ha un patrimonio netto totale di ₹14.7B e un debito totale di ₹1.7B, che porta il suo rapporto debito/patrimonio netto a 11.8%. Le sue attività totali e le sue passività totali sono rispettivamente ₹18.6B e ₹3.9B. L'EBIT di Poly Medicure è ₹3.1B rendendo il suo rapporto di copertura degli interessi 25.6. Ha liquidità e investimenti a breve termine pari a ₹2.9B.
Informazioni chiave
11.8%
Rapporto debito/patrimonio netto
₹1.74b
Debito
| Indice di copertura degli interessi | 25.6x |
| Contanti | ₹2.86b |
| Patrimonio netto | ₹14.70b |
| Totale passività | ₹3.89b |
| Totale attività | ₹18.59b |
Aggiornamenti recenti sulla salute finanziaria
Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( ₹8.4B ) di POLYMED superano le sue passività a breve termine ( ₹3.5B ).
Passività a lungo termine: Le attività a breve termine di POLYMED ( ₹8.4B ) superano le sue passività a lungo termine ( ₹373.8M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: POLYMED ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di POLYMED si è ridotto da 35.9% a 11.8% negli ultimi 5 anni.
Copertura del debito: Il debito di POLYMED è ben coperto dal flusso di cassa operativo ( 152.8% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di POLYMED sono ben coperti dall'EBIT ( 25.6 x copertura).